Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/25/2026

1. AKAM
2. COST
3. SPY
4. ZS
5. META
6. NVDA
7. DRI
8. ULS
9. PRME
10. CRL

Go back to Mast To Develop Vepoloxamer (MST-188) In Chronic Heart Failure
MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 19.54 -0.92 (4.5%)
Previous Close $20.46    52 Week High $0.71 
Open $20.62    52 Week Low $0.07 
Day High $20.65    P/E N/A 
Day Low $19.21    EPS $-0.35 
Volume 4,003,618       

MAST THERAPEUTICS, Inc. (NASDAQ: MSTX) Delayed: 19.54 -0.92 (4.5%)
Previous Close $20.46    52 Week High $0.71 
Open $20.62    52 Week Low $0.07 
Day High $20.65    P/E N/A 
Day Low $19.21    EPS $-0.35 
Volume 4,003,618